CPT® Code 96366

Add-On Code

Quick Reference

• Code definition: Add-on code for each additional hour of intravenous infusion of the same drug or substance beyond the initial hour billed under 96365, used for therapeutic, prophylactic, or diagnostic infusions.
• Key billing rule: 96366 is a "+" add-on code; it cannot stand alone. 96365 must appear on the same claim for the same date of service, or the claim auto-denies. MUE = 8 units per date of service [5].
• 30-minute threshold: Each unit of 96366 requires a full additional hour or a partial hour of at least 30 minutes beyond the preceding billed hour. A 29-minute tail does not qualify for another unit.
• Documentation must-have: Clock-time start and stop times are required in the nursing record. Without exact times, payers cannot validate the number of units billed; missing stop times are the single most common denial trigger for this code [3][4].
• Top confusion point: Do not use 96366 when a different drug is infused sequentially after the first drug ends. That scenario requires 96367. Using 96366 for a new substance misrepresents the service and constitutes a misrepresentation on the claim.
• Chemotherapy boundary: If the infused drug is a recognized chemotherapy agent, the correct add-on is 96415, not 96366. Drug classification governs code selection, not the administration method.
• Incident-to billing: PC/TC Indicator 5 confirms this code reports as incident-to. Infusion nurses may administer under physician general supervision in the office setting; the physician must have initiated the plan and be immediately available [3].

When to Use This Code

96366 captures the time-extended portion of a single therapeutic, prophylactic, or diagnostic IV infusion. It applies whenever the same drug or substance that triggered 96365 continues infusing beyond the first hour.

Clinical scenarios where 96366 applies:

• Biologic infusions (infliximab, rituximab, tocilizumab, natalizumab) that routinely run 2 to 4 hours per protocol
• IVIG infusions for immune deficiencies, CIDP, or Guillain-Barré syndrome, which frequently extend 3 to 6 hours
• Prolonged IV antibiotic courses (vancomycin, ertapenem) administered over 2 to 4 hours
• Iron infusions (ferric carboxymaltose, iron sucrose) requiring extended administration times
• IV corticosteroids (methylprednisolone) and bisphosphonates (zoledronic acid) with multi-hour protocols

Scope boundaries: 96366 applies only to the non-chemotherapy, non-hydration range (96360 to 96379). Hydration infusions use 96361 as their add-on. Chemotherapy drugs use 96415. A single encounter can shift between code families when different drug types are administered sequentially.

Setting: Per CPT guidelines, codes 96360 to 96379 are not intended to be reported by the physician in the facility setting; they are used by outpatient hospital departments and physician office practices billing under the physician fee schedule at non-facility sites. In the facility setting, the hospital bills the infusion codes; a physician billing on the same date reports any separately identifiable E/M with modifier 25 [1].

Timed code unit calculation:

96366 follows the 30-minute rule established by CMS and confirmed by AMA CPT Assistant [2]:

Infusion time starts when the infusion begins and ends when the infusion is complete. Flush time is excluded. Brief routine interruptions (such as IV bag changes) do not stop the infusion clock as long as the infusion remains continuous [2].

Code Differentiation Table

The critical distinction between 96366 and 96367 is drug identity, not time. As long as the same substance continues, every additional qualifying hour is 96366. The moment a new drug begins sequentially after the first drug ends, 96367 governs that new drug's first hour. These two codes should never appear on the same claim for the same drug on the same date.

flowchart TD
    A[IV infusion beyond initial hour] --> B{Same drug or new drug?}
    B -- Same drug continues --> C{Is it a chemotherapy agent?}
    B -- New drug, sequential --> D[96367 for new drug first hour]
    B -- Second drug running simultaneously --> E[96368 concurrent, report once]
    C -- No --> F[96366 per additional hour]
    C -- Yes --> G[96415 per additional hour]
    D --> H{Also a chemo drug?}
    H -- No --> I[96367]
    H -- Yes --> J[96413 for initial chemo hour, then 96415]

Billing and Modifier Rules

Add-on code constraints: 96366 carries a ZZZ global day indicator, meaning it inherits the global period of its primary procedure (96365). It cannot be reported without 96365 on the same date [1].

MUE = 8 units per date of service [5]: At 8 units, the ceiling is 9 total hours of therapeutic infusion per date (1 hour from 96365 plus 8 from 96366). This accommodates prolonged IVIG and most biologic protocols without issue. Claims submitting more than 8 units auto-deny at the MUE adjudication level.

Modifier usage:

• Modifier 25: Apply to the E/M service code on the same date if a significant, separately identifiable office visit occurs. Do not apply modifier 25 to 96366 itself; infusion codes are not E/M services. CPT guidelines confirm that a separate diagnosis is not required for the same-day E/M [1].
• Modifier 59: Rarely indicated for 96366 specifically, but may be used to bypass an incorrect NCCI edit where the service is genuinely separate and distinct.
• Modifiers JA, JW: These apply to the drug HCPCS line (J-code), not to 96366. Modifier JA (administered intravenously) is required by some MACs on the drug code. Modifier JW (drug discarded) also attaches to the J-code.
• Modifier GY: Use on the claim when billing a non-covered infusion to Medicare for the purpose of generating a denial for secondary insurance billing. Apply to 96366 and 96365 as appropriate.

Bundling rules [6]:

• 96366 and 96367 should not both appear for the same drug on the same date; that constitutes unbundling.
• 96360/96361 (hydration) cannot serve as the primary service when 96365/96366 are also reported. Therapeutic infusion takes hierarchy precedence over hydration as the primary service.
• Do not apply 96366 to concurrent infusions. 96368 has no time-based extension; it is reported once per encounter regardless of concurrent drug count.

Same-day repeated infusions (facility example): AMA CPT guidelines provide a specific example: a patient in observation receives the same antibiotic every 8 hours on the same date through the same IV access. The facility reports 96365 for the first dose and 96366 twice (for the second and third doses), applying the hierarchy that treats each one-hour infusion of the same drug as an additional hour [1].

Documentation Essentials

Required elements per CMS Medicare Benefit Policy Manual Chapter 15 and MLN MM5533 [3][4]:

• Physician order: Drug name, dose, route (IV), rate, and anticipated duration must be written before the infusion begins
• Drug name and dose: The CPT descriptor specifies "specify substance or drug"; the exact agent must be identified in the record
• Start and stop times: Clock times (e.g., "10:05 to 13:20") are the most critical documentation element for 96366. Without them, the number of units cannot be calculated or verified by the payer
• Infusion rate or method: Pump settings or gravity flow rate in nursing notes
• Monitoring notes: Nursing documentation of vital signs, patient tolerance, and any adverse reactions during infusion
• Supervising provider identification: Name of the responsible physician or qualified NPP; general supervision applies for most therapeutic infusions in the office setting
• Medical necessity: The ICD-10-CM diagnosis must align with the drug's indication and any applicable LCD criteria; coverage is drug-dependent, not procedure-dependent

Audit red flags specific to 96366:

• Nursing notes present but start or stop time missing or illegible; this is the most audited documentation gap for infusion add-on codes
• Total time documented but clock times absent; auditors require actual clock times, not just a duration narrative
• Units billed do not correlate with documented total infusion time; a 90-minute infusion cannot support more than one unit of 96366
• Drug administered is a chemotherapy agent but 96366 was billed instead of 96415; auditors cross-reference drug J-codes against the administration code billed

Medicare, Commercial and Medicaid Payer Rules

Medicare:

Coverage for 96366 is contingent on the medical necessity of the specific drug infused. CMS does not have a universal NCD for therapeutic infusion administration. Coverage is determined at the drug level through MAC-published LCDs [7]:

• IVIG: Multiple MACs (Palmetto GBA, NGS, Noridian) publish LCDs listing covered ICD-10-CM diagnoses
• Iron infusions: MAC LCDs define covered diagnoses and allowable frequency
• Biologic infusions (RA, Crohn's disease, MS): Drug-specific LCDs with diagnosis and trial-of-therapy requirements

MUE = 8 units at the date-of-service adjudication level [5]. No CMS-specific G-code substitution applies to 96366.

Place of service affects payment rates: POS 11 (office) generates non-facility RVU-based payment for both the administration code and the drug. POS 22 (outpatient hospital) and POS 19 (off-campus outpatient) route payment through OPPS/APC; the hospital bills administration, and only an E/M or direct supervision visit is separately billable by the physician [8].

Under OPPS, 96368 (concurrent) is APC-packaged per the OPPS final rule; it does not generate a separate APC payment in the facility setting. 96365, 96366, and 96367 carry APC status indicator S "not discounted when multiple" and do generate separate APC payments [8][9].

Frequency limitations are not imposed at the 96366 code level by CMS; they are imposed at the drug level through LCD medical necessity criteria.

Commercial payers:

Prior authorization requirements vary by drug, not by administration code. For high-cost biologics (infliximab, rituximab, natalizumab), commercial payers typically require prior authorization tied to the drug J-code. Denial of the prior authorization for the drug effectively denies the administration code as well. Confirm drug authorization before scheduling infusions for commercial patients.

Some commercial payers apply automated downcoding rules if documentation submitted on appeal does not include clock times; the correction policy mirrors Medicare's documentation requirements.

Common Denials and Prevention

Missing or incomplete start/stop times The most frequent denial for 96366. Payers require clock times to calculate billable units; a duration statement ("infused for 3 hours") without times is insufficient for most MACs and commercial payers. Prevention: implement a mandatory infusion flow sheet that requires time-in and time-out fields before the nursing note can be closed [3][4].

96366 billed without 96365 on the same claim Occurs most often in split-billing environments where the drug and administration codes are on separate claims, or when 96365 is removed during claim scrubbing. NCCI logic auto-denies 96366 without its primary. Prevention: run a claim integrity check confirming 96365 is present before submission; do not separate drug and administration code billing to different entities for the same encounter [6].

Units exceed documented time Billing three units of 96366 when documented time supports only two. Auditors calculate units from start/stop times and compare against billed units. Prevention: build a unit calculation step into the billing workflow using clock time from the nursing note before entering units.

Wrong code for drug type Billing 96366 when the drug is a chemotherapy agent (should be 96415) or billing 96366 for a sequentially different drug (should be 96367). Cross-referencing the J-code against the drug classification table in the chargemaster at the time of coding catches this before submission. Oncology practices especially should confirm drug classification before defaulting to 96366 [1].

Exceeding MUE of 8 Claims with more than 8 units of 96366 on a single date auto-deny. For protocols genuinely requiring more than 9 total hours, submit with documentation and a narrative; manual review is required [5].

Coding Scenarios

Scenario 1: A patient with rheumatoid arthritis presents to an infusion suite for infliximab (Remicade). The RN documents infusion start at 09:00 and stop at 11:05. The physician's order specifies dose, rate, and duration. The patient tolerates the infusion without adverse events.

Correct coding: 96365 × 1, 96366 × 1, J1745 (infliximab, per 10 mg) × applicable units

Why: 2 hours 5 minutes total; the 5-minute tail after the second hour does not meet the 30-minute threshold for a third unit of 96366. Same drug throughout, so 96366 applies, not 96367.

Scenario 2: A patient with CIDP receives IVIG (Gammagard) at a physician's infusion office. Nursing notes document 08:30 start and 12:45 stop. RN records drug lot number and dose. The supervising physician is present in the suite.

Correct coding: 96365 × 1, 96366 × 3, applicable IVIG J-code × units

Why: 4 hours 15 minutes total. Hours 2, 3, and 4 each qualify as a full additional hour. The 15-minute tail does not reach the 30-minute threshold. MUE of 8 is not approached. Incident-to billing applies; the supervising physician's presence satisfies general supervision requirements.

Scenario 3: A hospital outpatient infusion center patient receives ondansetron IV over 30 minutes, followed by paclitaxel IV over 3 hours through the same access.

Correct coding: 96365 × 1 (ondansetron, initial), 96413 × 1 (paclitaxel, initial chemo hour), 96415 × 2 (paclitaxel hours 2 and 3)

Why: Once the chemotherapy drug begins, the chemotherapy code family governs. Do not use 96366 or 96367 for paclitaxel; drug classification controls code selection regardless of infusion method. The facility bills these codes; the attending physician bills separately only for any independently identifiable E/M with modifier 25.

Scenario 4: An outpatient clinic submits a claim for 96365 × 1 and 96366 × 2 for IV antibiotic administration. The nursing note records start time (14:00) but no stop time. The claim is denied for 96366.

Correct coding after correction: Obtain the nursing notes with verified stop time; recalculate units from clock time; resubmit with complete documentation.

Why: Without a documented stop time, the payer cannot confirm that 2 additional hours were provided. The claim is correctly denied. The fix is documentation correction followed by resubmission with appeal documentation, not a modifier.

Related Codes

• 96365 — IV infusion, therapy/prophylaxis/diagnosis; initial, up to 1 hour; required primary for 96366
• 96367 — IV infusion; additional sequential infusion of a new drug/substance, up to 1 hour; use when a different drug follows sequentially
• 96368 — IV infusion; concurrent infusion; used once per encounter when a second drug infuses simultaneously
• 96360 — IV infusion, hydration; initial, 31 minutes to 1 hour; primary code for crystalloid/hydration-only infusions
• 96361 — IV infusion, hydration; each additional hour; add-on parallel to 96366 for the hydration code family
• 96413 — Chemotherapy administration, IV infusion; up to 1 hour; use when initial infused drug is a chemotherapy agent
• 96415 — Chemotherapy administration, IV infusion; each additional hour; chemotherapy counterpart to 96366

Sources

1. AMA CPT Professional Edition 2025 — Official CPT code descriptors, add-on code rules, infusion section guidelines, and same-day E/M guidance
2. AMA CPT Assistant — July 2008 (infusion timing and flush time); September 2009 (interruptions); November 2014 (30-minute rule reaffirmation)
3. CMS Medicare Benefit Policy Manual, Chapter 15 — Section 50 infusion therapy coverage requirements and documentation standards
4. CMS MLN Matters MM5533 — Introduced current infusion code hierarchy; documentation requirements; supervision rules
5. CMS MUE Tables — MUE values for all CPT codes; 96366 MUE = 8 units per date of service
6. CMS NCCI Policy Manual, Chapter 11 — Medicine services NCCI edits; drug administration bundling rules
7. CMS Medicare Coverage Database — LCD and NCD search for drug-specific infusion coverage criteria
8. CMS OPPS 2025 Final Rule (CMS-1809-FC) — APC assignments and packaging policies; 96368 packaged status; 96366 APC status indicator confirmed
9. HHS OIG Work Plan — Compliance risk areas for infusion therapy; upcoding and unbundling audit history